Quick Answer
BIO-PATH HOLDINGS, INC. reported Total Revenue of $0.00 for fiscal year 2018.
BIO-PATH HOLDINGS, INC. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | -$9.89M +38.5% |
-$16.08M -15.9% |
-$13.87M -32.8% |
-$10.44M +4.1% |
-$10.88M -26.5% |
-$8.60M -0.2% |
| Diluted EPS | -$4.12 +87.7% |
-$33.63 +11.8% |
-$38.12 -2359.4% |
-$1.55 +45.2% |
-$2.83 | — |
| Total Assets | $3.88M +20.6% |
$3.22M -79.8% |
$15.97M -39.9% |
$26.57M +61.3% |
$16.48M -27.3% |
$22.66M +790.4% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $154.0K -65.1% |
$441.0K -96.9% |
$14.17M -44.3% |
$25.46M +68.9% |
$15.07M -28.5% |
$21.09M +1631.2% |
| R&D Expense | $7.29M -37.2% |
$11.61M +26.7% |
$9.16M +55.1% |
$5.91M -10.2% |
$6.58M +43.5% |
$4.58M -0.4% |
| Operating Income | -$11.99M +24.3% |
-$15.84M -14.0% |
-$13.90M -33.1% |
-$10.44M +4.3% |
-$10.91M -25.5% |
-$8.69M -1.2% |
| Shares Outstanding | 5.77M +833.3% |
618,000 +55.3% |
398,000 -94.4% |
7.16M +57.6% |
4.54M +23.0% |
3.69M +442.9% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2017 | $0.00 | — | — |
| Net Income | September 30, 2025 | -$976.0K | +53.9% | +78.8% |
| Diluted EPS | September 30, 2025 | -$0.11 | +84.3% | +80.0% |
| Total Assets | September 30, 2025 | $690.0K | -76.7% | -7.5% |
| Long-Term Debt | September 30, 2015 | $0.00 | — | — |
| Stockholders Equity | September 30, 2025 | -$8.00M | -1024.2% | -11.8% |
| R&D Expense | September 30, 2025 | $275.0K | -79.1% | -93.2% |
| Operating Income | September 30, 2025 | -$488.0K | +81.5% | +89.3% |
| Shares Outstanding | September 30, 2025 | 9.24M | +149.1% | +11.2% |
- BIO-PATH HOLDINGS, INC. reported Total Revenue of $0.00 for fiscal year 2018.
- BIO-PATH HOLDINGS, INC. showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- BIO-PATH HOLDINGS, INC. reported Net Income of -$9.89 million for fiscal year 2024.
- BIO-PATH HOLDINGS, INC. showed an increase of +38.5% in Net Income compared to the prior fiscal year.
- BIO-PATH HOLDINGS, INC. reported Diluted EPS of $4.12 per share (loss) for fiscal year 2024.
- BIO-PATH HOLDINGS, INC. showed an increase of +87.7% in Diluted EPS compared to the prior fiscal year.
- BIO-PATH HOLDINGS, INC. reported Total Assets of $3.88 million for fiscal year 2024.
- BIO-PATH HOLDINGS, INC. showed an increase of +20.6% in Total Assets compared to the prior fiscal year.
- BIO-PATH HOLDINGS, INC. reported Long-Term Debt of $0.00 for fiscal year 2015.
- BIO-PATH HOLDINGS, INC. reported Stockholders Equity of $154.0 thousand for fiscal year 2024.
- BIO-PATH HOLDINGS, INC. showed a decrease of -65.1% in Stockholders Equity compared to the prior fiscal year.
- BIO-PATH HOLDINGS, INC. reported R&D Expense of $7.29 million for fiscal year 2024.
- BIO-PATH HOLDINGS, INC. showed a decrease of -37.2% in R&D Expense compared to the prior fiscal year.
- BIO-PATH HOLDINGS, INC. reported Operating Income of -$11.99 million for fiscal year 2024.
- BIO-PATH HOLDINGS, INC. showed an increase of +24.3% in Operating Income compared to the prior fiscal year.
- BIO-PATH HOLDINGS, INC. reported Shares Outstanding of 5.77 million shares for fiscal year 2024.
- BIO-PATH HOLDINGS, INC. showed an increase of +833.3% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: